107 related articles for article (PubMed ID: 24712396)
1. Epidermal growth factor receptor (EGFR) mutations as biomarker for head and neck squamous cell carcinomas (HNSCC).
Nagalakshmi K; Jamil K; Pingali U; Reddy MV; Attili SS
Biomarkers; 2014 May; 19(3):198-206. PubMed ID: 24712396
[TBL] [Abstract][Full Text] [Related]
2. Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma.
Khattri A; Zuo Z; Brägelmann J; Keck MK; El Dinali M; Brown CD; Stricker T; Munagala A; Cohen EE; Lingen MW; White KP; Vokes EE; Seiwert TY
Oral Oncol; 2015 Jan; 51(1):53-8. PubMed ID: 25255959
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.
Temam S; Kawaguchi H; El-Naggar AK; Jelinek J; Tang H; Liu DD; Lang W; Issa JP; Lee JJ; Mao L
J Clin Oncol; 2007 Jun; 25(16):2164-70. PubMed ID: 17538160
[TBL] [Abstract][Full Text] [Related]
4. Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma.
Sheikh Ali MA; Gunduz M; Nagatsuka H; Gunduz E; Cengiz B; Fukushima K; Beder LB; Demircan K; Fujii M; Yamanaka N; Shimizu K; Grenman R; Nagai N
Cancer Sci; 2008 Aug; 99(8):1589-94. PubMed ID: 18754871
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
[TBL] [Abstract][Full Text] [Related]
6. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
[TBL] [Abstract][Full Text] [Related]
7. EGFR codon 497 polymorphism - implications for receptor sensitivity to inhibitors in HNSCC cell lines.
Krohn V; Wiegand S; Werner JA; Mandic R
Anticancer Res; 2011 Jan; 31(1):59-65. PubMed ID: 21273581
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC).
Stoehlmacher-Williams J; Obermann L; Ehninger G; Goekkurt E
Anticancer Res; 2012 Feb; 32(2):421-5. PubMed ID: 22287728
[TBL] [Abstract][Full Text] [Related]
9. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas.
Szabó B; Nelhubel GA; Kárpáti A; Kenessey I; Jóri B; Székely C; Peták I; Lotz G; Hegedus Z; Hegedus B; Füle T; Döme B; Tímár J; Tóvári J
Oral Oncol; 2011 Jun; 47(6):487-96. PubMed ID: 21498106
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of EGFR Tyrosine Kinase Domain Mutations in Head and Neck Squamous Cell Carcinoma: Cohort Study and Systematic Review.
Perisanidis C
In Vivo; 2017 Jan; 31(1):23-34. PubMed ID: 28064216
[TBL] [Abstract][Full Text] [Related]
12. Absence of activating mutations in the EGFR kinase domain in Spanish head and neck cancer patients.
Lemos-González Y; Páez de la Cadena M; Rodríguez-Berrocal FJ; Rodríguez-Piñeiro AM; Pallas E; Valverde D
Tumour Biol; 2007; 28(5):273-9. PubMed ID: 17962724
[TBL] [Abstract][Full Text] [Related]
13. Expression and mutation analysis of her2 in head and neck squamous cell carcinoma.
Ali MA; Gunduz M; Gunduz E; Tamamura R; Beder LB; Katase N; Hatipoglu OF; Fukushima K; Yamanaka N; Shimizu K; Nagatsuka H
Cancer Invest; 2010 Jun; 28(5):495-500. PubMed ID: 20014947
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N
Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548
[TBL] [Abstract][Full Text] [Related]
15. Involvement of EGFR in the response of squamous cell carcinoma of the head and neck cell lines to gefitinib.
Taguchi T; Tsukuda M; Imagawa-Ishiguro Y; Kato Y; Sano D
Oncol Rep; 2008 Jan; 19(1):65-71. PubMed ID: 18097577
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the EGFR mutation status in head and neck squamous cell carcinoma before treatment with Gefitinib.
Bontognali S; Pless M; Brutsche MH; Fischer C; Rochlitz C; Buess M
Onkologie; 2013; 36(4):161-6. PubMed ID: 23548963
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas: tyrosine kinase domain mutations are not rare in tumors with an adenocarcinoma component.
Ohtsuka K; Ohnishi H; Fujiwara M; Kishino T; Matsushima S; Furuyashiki G; Takei H; Koshiishi Y; Goya T; Watanabe T
Cancer; 2007 Feb; 109(4):741-50. PubMed ID: 17238183
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor--its expression and copy numbers of EGFR gene in patients with head and neck squamous cell carcinomas.
Mrhalova M; Plzak J; Betka J; Kodet R
Neoplasma; 2005; 52(4):338-43. PubMed ID: 16059652
[TBL] [Abstract][Full Text] [Related]
19. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.
Kropveld A; Rozemuller EH; Leppers FG; Scheidel KC; de Weger RA; Koole R; Hordijk GJ; Slootweg PJ; Tilanus MG
Lab Invest; 1999 Mar; 79(3):347-53. PubMed ID: 10092071
[TBL] [Abstract][Full Text] [Related]
20. Identification of the rare EGFR mutation p.G796S as somatic and germline mutation in white patients with squamous cell carcinoma of the head and neck.
Schwentner I; Witsch-Baumgartner M; Sprinzl GM; Krugmann J; Tzankov A; Jank S; Zwierzina H; Loeffler-Ragg J
Head Neck; 2008 Aug; 30(8):1040-4. PubMed ID: 18528899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]